A detailed history of Binnacle Investments Inc transactions in Incyte Corp stock. As of the latest transaction made, Binnacle Investments Inc holds 189 shares of INCY stock, worth $12,921. This represents 0.01% of its overall portfolio holdings.

Number of Shares
189
Holding current value
$12,921
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 13, 2025

BUY
$60.0 - $75.26 $11,340 - $14,224
189 New
189 $11.4 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.2B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Binnacle Investments Inc Portfolio

Follow Binnacle Investments Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Binnacle Investments Inc, based on Form 13F filings with the SEC.

News

Stay updated on Binnacle Investments Inc with notifications on news.